Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM6 pseudogene 2 (abbreviated as TOMM6P2) is a designated pseudogene related to the TOMM6 gene (Translocase of Outer Mitochondrial Membrane 6), which encodes a mitochondrial membrane protein potentially involved in protein insertion processes[3]. Pseudogenes, including TOMM6P2, are typically noncoding genomic sequences derived from ancestral genes, which have lost their ability to produce functional proteins through mutation, duplication, or retrotransposition[7]. While some rare pseudogenes may regulate their parent genes via RNA-mediated mechanisms (such as ceRNA or microRNA sponging)[2][7], there is no supporting data that TOMM6P2 is transcribed or functions as such. TOMM6P2 is not considered an enzyme, receptor, or therapeutic target and does not belong to a recognized protein family, molecular pathway, or disease association. It is only noted in the context of genomic nomenclature and does not possess clinical, biological, or pharmacological relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOMM6 pseudogene 2 (TOMM6P2).